- ToMORROW has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.
- ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains.
Out of Stock
Boehringer Ingelheim Tomorrow Cephapirin Syringe (10 ml) ( each)
Sold as individual syringes – ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.
$6.99
Out of stock
Out of Stock
